Mallinckrodt's Tramadol Promotions Draw FDA Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency's advertising division asks company to stop using exhibit panel for the generic opioid. The promotion omits risk information and fails to note that tramadol is only indicated for adults, FDA says.